Del 159 - Progress in Molecular Biology and Translational Science

Progress in Molecular Biology and Translational Science

Inbunden, Engelska, 2018

2 319 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Progress in Molecular Biology and Translational Science, Volume 159, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to prions, viruses, bacteria and eukaryotes. The series includes in-depth knowledge on molecular biological aspects of organismal physiology, along with insights on how this knowledge may be applied to understand and ameliorate human disease. New chapters in this release discuss timely topics, such as Targeting recently deorphanized GPR83 for the treatment of infection, stress, and drug addiction, Arrestin Structure-Function, Arrestins in the Cardiovascular System, Analysis of biased agonism, and more.

Includes comprehensive coverage of molecular biology
Presents ample use of tables, diagrams, schemata, and color figures to enhance the reader's ability to rapidly grasp the information provided
Contains contributions from renowned experts in the field

Produktinformation

Utgivningsdatum2018-10-26
Mått152 x 229 x undefined mm
Vikt450 g
FormatInbunden
SpråkEngelska
SerieProgress in Molecular Biology and Translational Science
Antal sidor218
FörlagElsevier Science
ISBN9780128162354

Tillhör följande kategorier

Biologi inom Naturvetenskap och teknik

David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.

1. Targeting recently deorphainzed GPR83 for the treatment of infection, stress, drug addictionLakshmi A. Devi2. Arrestin Structure-FunctionVsevolod V. Gurevich3. Arrestins in the Cardiovascular SystemAnastasios Lymperopoulos4. Analysis of biased agonismFrederick Ehlert5. Roles of different subtypes of estrogen receptors in cancer cell metabolismHaifei Shi6. Arrrestins in cell migration or Arrestins in inflammationKathryn Defea